Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 49
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 8.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Design, Physicochemical Evaluation and In Vitro Dissolution Studies of Transdermal Patches Containing Aceclofenac

IRFAN NEWAZ KHANA, MARZINA AJRINA, MD. RAZIBUL HABIB*B, MARIA ISLAM KHANA , MD. MOMINUR RAHMANB, MOHAMMAD SHOHELC

The present study was designed to develop a suitable matrix type transdermal drug delivery system (TDDS) of Aceclofenac using blends of three different polymeric combinations of Polyvinyl pyrrolidine (PVP) and ethylcellulose (EC). Physical studies including moisture content, moisture uptake, flatness to study the stability of the formulations and in vitro dissolution of the experimental formulations were performed. It was observed that as the concentration of the hydrophilic polymer, PVP, increased in the formulation, the rate of dissolutions increased subsequently and the best result found for the polymer ratio 3:5. From the study of release mechanism it was found that the higuchi plot showed reasonably straight line with high correlation coefficient. It was also found that there were no significant reactions developed during the contact of patch with the dermis. Hence, it can be reasonably concluded that Aceclofenac can be formulated into the transdermal matrix type patches to sustain its release characteristics and the polymeric composition (PVP/EC, 3:5) was found to be the best choice for manufacturing transdermal patches of Aceclofenac among the formulations studied.